Vytorin 10/80 mg (ezetimibe / simvastatin 10/80 mg) — CareFirst (Caremark)
Established coronary heart disease, cerebrovascular disease, peripheral vascular disease, and/or diabetes at high risk of coronary heart disease events
Initial criteria
- The patient has been taking the 10/80 mg strength of ezetimibe/simvastatin (Vytorin) OR the 80 mg strength of simvastatin (Zocor) chronically for 12 months or more.
Approval duration
36 months